Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
about
Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffersExome-wide Association Study Identifies CLEC3B Missense Variant p.S106G as Being Associated With Extreme Longevity in East Asian Populations.Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study.High Intratumoral Expression of Tetranectin Associates with Poor Prognosis of Patients with Gastric Cancer after Gastrectomy.The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation.Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
P2860
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@ast
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@en
type
label
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@ast
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@en
prefLabel
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@ast
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@en
P2093
P2860
P356
P1476
Aberrant tetranectin expression in human breast carcinomas as a predictor of survival
@en
P2093
Amberger A
Brunhuber T
Christiansen M
Ensinger C
Margreiter R
P2860
P304
P356
10.1136/JCP.2003.010058
P407
P577
2004-04-01T00:00:00Z